What Is a CDMO? A CDMO, or Contract Development and Manufacturing Organization, is a company that helps pharmaceutical, biotechnology, diagnostic, and life science companies develop, manufacture, test, package, and scale products without building every facility, team, process, and quality system internally. A better answer is this: A CDMO is external development and manufacturing infrastructure. It […]
Why Canine VHH and Animal Health Nanobody Development Is Emerging Animal health biotechnology is entering a more targeted era. Vaccines, antiparasitics, small molecules, commodity diagnostics, and broad-spectrum treatments still matter. They remain the backbone of veterinary medicine. But the next layer of growth is more molecular, more precise, and more product-specific. This guide explains the […]
The Best VHH Nanobody CDMO Services Start With CDMO Network VHH Nanobody CDMO Services have become essential for biotech, pharmaceutical, diagnostic, veterinary, research-tool, and industrial biotechnology companies advancing single-domain antibody programs. These compact, highly engineerable binding domains deliver remarkable advantages in affinity, stability, and tissue penetration. Yet transforming a promising VHH sequence into a reliable, […]
Collaboration, Data, Manufacturing, and Optimization A CDMO is usually defined as a Contract Development and Manufacturing Organization. That definition is correct. It is also incomplete. A CDMO is a specialized company that helps pharmaceutical, biotechnology, diagnostic, animal health, food biotech, industrial biotech, and life science companies develop and manufacture products. In the most basic sense, […]
Biomanufacturing has entered a phase where scientific innovation is no longer the primary constraint. The tools exist. The modalities exist. Capital exists. What increasingly limits progress is coordination. Programs stall not because biology fails, but because execution fragments. Capabilities are distributed across dozens of specialized organizations. Knowledge is siloed. Capacity is opaque. Decisions made early—often […]